
Originally Posted by
numbere
Oh jeez this is still going on.
I read that study two years ago.
It's a retrospective cohort study.
This means it suffers from selection bias, information bias and many statics simply cannot be measured.
When you conduct a study with the sole intention of finding side effects you find a lot of side effects, even if they aren't statistically significant for the population at large.
The median age of participants 61 and the range was 30-79 years old.
That's not even close to the average age range that uses PCT.
The study doesn't say how much tamoxifen the patients were taking or how long they were taking the drug, but it was probably years.
A lot of those guys were in poor condition because 9 of the 64 died soon after stopping tamoxifen.
We have no idea if any of those 9 were of the in the group of 3 that suffered ocular events.
We have no idea if any of the patients were on other medications to try and prolong their life.
I believe I've read every scientific paper out on tamoxifen.
There was an Anelli study done in 1993 on the side effects of tamoxifen with 24 participants.
No ocular events were measured in the Anelli study.
The chance of a healthy individual having an ocular event from tamoxifen is less than one percent.